415 related articles for article (PubMed ID: 17530315)
1. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
Fischer P; Hilfiker-Kleiner D
Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
[TBL] [Abstract][Full Text] [Related]
2. Survival pathways in hypertrophy and heart failure: the gp130-STAT axis.
Fischer P; Hilfiker-Kleiner D
Basic Res Cardiol; 2007 Sep; 102(5):393-411. PubMed ID: 17918316
[TBL] [Abstract][Full Text] [Related]
3. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
[TBL] [Abstract][Full Text] [Related]
4. p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
Fahmi A; Smart N; Punn A; Jabr R; Marber M; Heads R
Cell Signal; 2013 Apr; 25(4):898-909. PubMed ID: 23268184
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
6. Exercise rescued chronic kidney disease by attenuating cardiac hypertrophy through the cardiotrophin-1 -> LIFR/gp 130 -> JAK/STAT3 pathway.
Chen KC; Hsieh CL; Peng CC; Peng RY
Eur J Prev Cardiol; 2014 Apr; 21(4):507-20. PubMed ID: 23064267
[TBL] [Abstract][Full Text] [Related]
7. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
Kurdi M; Booz GW
J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
[TBL] [Abstract][Full Text] [Related]
8. Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance.
Zolk O; Ng LL; O'Brien RJ; Weyand M; Eschenhagen T
Circulation; 2002 Sep; 106(12):1442-6. PubMed ID: 12234945
[TBL] [Abstract][Full Text] [Related]
9. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of N-glycosylation of glycoprotein 130 molecule abolishes STAT3 activation by IL-6 family cytokines in cultured cardiac myocytes.
Matsuo R; Morihara H; Mohri T; Murasawa S; Takewaki K; Nakayama H; Maeda M; Fujio Y
PLoS One; 2014; 9(10):e111097. PubMed ID: 25340554
[TBL] [Abstract][Full Text] [Related]
11. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways.
Yasukawa H; Hoshijima M; Gu Y; Nakamura T; Pradervand S; Hanada T; Hanakawa Y; Yoshimura A; Ross J; Chien KR
J Clin Invest; 2001 Nov; 108(10):1459-67. PubMed ID: 11714737
[TBL] [Abstract][Full Text] [Related]
12. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure.
González A; Ravassa S; Loperena I; López B; Beaumont J; Querejeta R; Larman M; Díez J
J Hypertens; 2007 Oct; 25(10):2148-57. PubMed ID: 17885560
[TBL] [Abstract][Full Text] [Related]
13. Cell type-specific STAT3 activation by gp130-related cytokines in the peripheral nerves.
Wang L; Lee HK; Seo IA; Shin YK; Lee KY; Park HT
Neuroreport; 2009 May; 20(7):663-8. PubMed ID: 19349921
[TBL] [Abstract][Full Text] [Related]
14. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
15. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
16. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
17. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.
Nakaoka Y; Nishida K; Fujio Y; Izumi M; Terai K; Oshima Y; Sugiyama S; Matsuda S; Koyasu S; Yamauchi-Takihara K; Hirano T; Kawase I; Hirota H
Circ Res; 2003 Aug; 93(3):221-9. PubMed ID: 12855672
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
19. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene.
Nakaoka Y; Shioyama W; Kunimoto S; Arita Y; Higuchi K; Yamamoto K; Fujio Y; Nishida K; Kuroda T; Hirota H; Yamauchi-Takihara K; Hirano T; Komuro I; Mochizuki N
J Mol Cell Cardiol; 2010 Aug; 49(2):157-64. PubMed ID: 20226789
[TBL] [Abstract][Full Text] [Related]
20. gp130-mediated pathway and heart failure.
Yamauchi-Takihara K
Future Cardiol; 2008 Jul; 4(4):427-37. PubMed ID: 19804322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
